D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Genetics D-index 58 Citations 14,008 155 World Ranking 2513 National Ranking 317

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Genetics
  • Mutation

Karen E. Morrison focuses on Genetics, Amyotrophic lateral sclerosis, Genome-wide association study, Gene and Haplotype. Her research investigates the connection between Genetics and topics such as Frontotemporal dementia that intersect with issues in Frameshift mutation. Her Amyotrophic lateral sclerosis study is related to the wider topic of Internal medicine.

Her Genome-wide association study research is multidisciplinary, incorporating elements of LRRK2, Locus and Candidate gene. Karen E. Morrison has included themes like Molecular biology, Annexin and Disease in her Gene study. Her studies in Haplotype integrate themes in fields like C9orf72, Trinucleotide repeat expansion, TARDBP, Allele frequency and Age of onset.

Her most cited work include:

  • Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study (798 citations)
  • VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death (768 citations)
  • EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) : revised report of an EFNS task force (584 citations)

What are the main themes of her work throughout her whole career to date?

The scientist’s investigation covers issues in Genetics, Amyotrophic lateral sclerosis, Disease, Gene and Internal medicine. Her is involved in several facets of Genetics study, as is seen by her studies on Genome-wide association study, Locus, Single-nucleotide polymorphism, Genetic association and Exon. Her work deals with themes such as Haplotype and Age of onset, which intersect with Single-nucleotide polymorphism.

Amyotrophic lateral sclerosis is a subfield of Pathology that Karen E. Morrison explores. Her work focuses on many connections between Disease and other disciplines, such as Bioinformatics, that overlap with her field of interest in Dementia and Genetic testing. Her Internal medicine research focuses on subjects like Oncology, which are linked to Cohort.

She most often published in these fields:

  • Genetics (56.65%)
  • Amyotrophic lateral sclerosis (46.31%)
  • Disease (22.66%)

What were the highlights of her more recent work (between 2013-2021)?

  • Amyotrophic lateral sclerosis (46.31%)
  • Genetics (56.65%)
  • Disease (22.66%)

In recent papers she was focusing on the following fields of study:

Karen E. Morrison mostly deals with Amyotrophic lateral sclerosis, Genetics, Disease, Genome-wide association study and Gene. Her study in Amyotrophic lateral sclerosis is interdisciplinary in nature, drawing from both Mutation, Genetic variation and Case-control study. Genetics is frequently linked to Parkinson's disease in her study.

Her research integrates issues of Genetic architecture, Locus and Heritability in her study of Genome-wide association study. Karen E. Morrison works mostly in the field of Locus, limiting it down to concerns involving Frontotemporal dementia and, occasionally, Genetic linkage. Her Gene research is multidisciplinary, incorporating perspectives in Protein aggregation and SOD1.

Between 2013 and 2021, her most popular works were:

  • Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis (289 citations)
  • Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease (252 citations)
  • Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease (252 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Genetics
  • Mutation

Her primary areas of study are Amyotrophic lateral sclerosis, Genetics, Genome-wide association study, Gene and Locus. Her study on Amyotrophic lateral sclerosis is covered under Internal medicine. Her Genetics study focuses mostly on Single-nucleotide polymorphism, HEK 293 cells, Kinase, Candidate gene and Exome sequencing.

Her Genome-wide association study research includes themes of Genetic predisposition, Project MinE, Minor allele frequency, Allele frequency and Genetic variation. The concepts of her Locus study are interwoven with issues in Frontotemporal dementia, Genetic association, Genotype, Imputation and Computational biology. The study incorporates disciplines such as Genetic linkage and Bioinformatics in addition to Frontotemporal dementia.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

Elisa Majounie;Alan E. Renton;Kin Mok;Elise G. P. Dopper;Elise G. P. Dopper.
Lancet Neurology (2012)

1119 Citations

EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) : revised report of an EFNS task force

Peter M. Andersen;Sharon Abrahams;Gian D. Borasio;Mamede de Carvalho.
European Journal of Neurology (2012)

1070 Citations

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

Diether Lambrechts;Erik Storkebaum;Masafumi Morimoto;Jurgen Del-Favero.
Nature Genetics (2003)

1063 Citations

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis

Matthew J Greenway;Peter M Andersen;Carsten Russ;Sean Ennis.
Nature Genetics (2006)

795 Citations

ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)

N. Parkinson;P. G. Ince;M. O. Smith;R. Highley.
Neurology (2006)

478 Citations

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

Wouter van Rheenen;Aleksey Shatunov;Annelot M. Dekker;Russell L. McLaughlin.
Nature Genetics (2016)

456 Citations

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Aude Nicolas;Kevin P. Kenna;Alan E. Renton;Alan E. Renton;Nicola Ticozzi.
Neuron (2018)

399 Citations

A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease

V. Plagnol;M.A. Nalls;J.M. Bras;D.G. Hernandez;D.G. Hernandez.
PLOS Genetics (2011)

350 Citations

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

A. Beilina;I. N. Rudenko;A. Kaganovich;L. Civiero.
Proceedings of the National Academy of Sciences of the United States of America (2014)

348 Citations

Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.

B N Smith;N Ticozzi;C Fallini;A S Gkazi.
Neuron (2014)

325 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Karen E. Morrison

Orla Hardiman

Orla Hardiman

Trinity College Dublin

Publications: 122

Ammar Al-Chalabi

Ammar Al-Chalabi

King's College London

Publications: 115

John Hardy

John Hardy

University College London

Publications: 84

Rosa Rademakers

Rosa Rademakers

Mayo Clinic

Publications: 83

Bryan J. Traynor

Bryan J. Traynor

National Institutes of Health

Publications: 82

Adriano Chiò

Adriano Chiò

University of Turin

Publications: 82

Peter M Andersen

Peter M Andersen

Umeå University

Publications: 81

Andrew B. Singleton

Andrew B. Singleton

National Institutes of Health

Publications: 81

Jan H. Veldink

Jan H. Veldink

Utrecht University

Publications: 80

Guy A. Rouleau

Guy A. Rouleau

Montreal Neurological Institute and Hospital

Publications: 77

Pamela J. Shaw

Pamela J. Shaw

University of Sheffield

Publications: 72

Peter Heutink

Peter Heutink

German Center for Neurodegenerative Diseases

Publications: 67

Leonard H. van den Berg

Leonard H. van den Berg

Utrecht University

Publications: 66

Glenda M. Halliday

Glenda M. Halliday

University of Sydney

Publications: 62

Christopher Shaw

Christopher Shaw

King's College London

Publications: 62

Albert C. Ludolph

Albert C. Ludolph

University of Ulm

Publications: 58

Trending Scientists

Xiaojun Chang

Xiaojun Chang

RMIT University

Lein Harn

Lein Harn

University of Missouri–Kansas City

Robert J. Aumann

Robert J. Aumann

Hebrew University of Jerusalem

Tim Loughran

Tim Loughran

University of Notre Dame

Maryam Rofougaran

Maryam Rofougaran

Broadcom (United States)

Frank Keller

Frank Keller

University of Edinburgh

Gerald Zon

Gerald Zon

TriLink BioTechnologies (United States)

Mark Gomelsky

Mark Gomelsky

University of Wyoming

James A. Johnston

James A. Johnston

Amgen (United States)

Mark S. Sands

Mark S. Sands

Washington University in St. Louis

Peter Croot

Peter Croot

National University of Ireland, Galway

Reza Shadmehr

Reza Shadmehr

Johns Hopkins University

Sampa Santra

Sampa Santra

Beth Israel Deaconess Medical Center

Michelle Luciano

Michelle Luciano

University of Edinburgh

Wolfgang Stremmel

Wolfgang Stremmel

Heidelberg University

Assen Jablensky

Assen Jablensky

University of Western Australia

Something went wrong. Please try again later.